Stay updated with breaking news from Associate Professor Mcclean. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results for the year ended 31 December 2022 Significant milestones reached, well capitalised and positioned for future growth LONDON, UK / ACCESSWIRE / March
Poolbeg Pharma plc completes in-licence of Melioidosis vaccine candidate
Poolbeg Pharma, 'Poolbeg' or the 'Company', a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has signed an Option Agreement to licence MelioVac, a vaccine for melioidosis, with University College Dublin and its inventor, Associate Professor Siobhán McClean, through NovaUCD, the university's knowledge transfer office.
TRADING UPDATES: Great Western notes good assays; Guild signs Villalba | Financial News